Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05789485 · ClinicalTrials.gov registry record · Phase 2

A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers

A Phase 2 study of Gastrointestinal Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Recruiting
Registry status
Phase 2
Development phase
216
Enrollment target
8
Study locations

NCT05789485 is a Phase 2 study of Gastrointestinal Cancer that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 216 participants, roughly in line with the 229-participant average among 48 other Gastrointestinal Cancer trials with a reported enrollment target. The trial reports 8 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05789485, a Phase 2 study of Gastrointestinal Cancer, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.

RECRUITING
Registry status
Phase 2
Development phase
216 participants
Enrollment target
8
Study locations

Study Summary

The purpose of this study is to find the level of aerobic exercise (AT) that is practical, is safe, and has positive effects on the body that may reduce the side effects of therapy. The study will also look at the way the body responds to exercise and whether there are differences in treatment. This will include looking at the highest treatment dose participants receive, how many people stop, delay, or reduce the treatment, and whether additional medication is needed to treat side effects of therapy.

Conditions Studied

Gastrointestinal Cancer

Interventions

  • BEHAVIORAL structured treadmill walking

Study Locations (8)

New York

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) - Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities) - Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities) - Rockville Centre

New Jersey

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) - Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) - Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) - Montvale

Connecticut

  • Hartford Healthcare Alliance (Data Collection Only) - Hartford

Trial Details

FieldValue
Enrollment Target 216 participants
Start Date 2023-04-28
Est. Completion 2027-04-18
Phase Phase 2

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05789485

The ClinicalTrials.gov registry entry for NCT05789485 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 229-participant average among 48 other Gastrointestinal Cancer trials with a reported enrollment target. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gastrointestinal Cancer appearing as the primary indexed condition, and to 1 intervention - of which structured treadmill walking is the first listed.

NCT05789485 reports 8 study locations spanning 3 distinct geographic areas - top geographies include New York, New Jersey, Connecticut.

Frequently Asked Questions

What is clinical trial NCT05789485 about?

NCT05789485 is a clinical study titled "A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers". The purpose of this study is to find the level of aerobic exercise (AT) that is practical, is safe, and has positive effects on the body that may reduce the side effects of therapy. The study will also look at the way the body responds to exercise and whether there are differences in treatment. This...

What is the current status of trial NCT05789485?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 216 participants. The study started on 2023-04-28. Estimated completion is 2027-04-18.

What conditions does trial NCT05789485 study?

This clinical trial studies the following conditions: Gastrointestinal Cancer.

What interventions are being tested in trial NCT05789485?

The interventions under investigation include: structured treadmill walking (BEHAVIORAL).

Who is sponsoring clinical trial NCT05789485?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05789485 being conducted?

This trial has 8 study locations across Connecticut, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Gastrointestinal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Gastrointestinal Cancer

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.